Point72 Hong Kong’s Enzo Biochem, Inc. ENZ Stock Holding History

Point72 Hong Kong’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,531	Closed	-$9K	–	1402
2019 Q2	$9K	Buy	+2,531	New	+$8.92K	﹤0.01%	868

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Hong Kong's ENZ Position: Q3 2019 in Review

Point72 Hong Kong sold out of Enzo Biochem, Inc. (ENZ) in Q3 2019, closing a stake of 2,531 shares — an estimated $9K sold.

Point72 Hong Kong first reported a position in ENZ in Q2 2019 and held it in 1 quarter. The position peaked at $9K in Q2 2019. 87 funds tracked by Wall St. Rank hold ENZ as of Q3 2019.

Point72 Hong Kong reported no remaining Enzo Biochem, Inc. position as of Q3 2019 after selling out during the quarter.
Point72 Hong Kong sold 2,531 Enzo Biochem, Inc. shares in Q3 2019, an estimated $9K.
Point72 Hong Kong first reported a position in Enzo Biochem, Inc. in Q2 2019 and held it in 1 quarter.
Point72 Hong Kong's Enzo Biochem, Inc. position peaked at $9K in Q2 2019.
87 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2019.

Based on Point72 Hong Kong's 13F filing for Q3 2019, filed 14 Nov 2019.